{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:20:39Z","timestamp":1790821239419,"version":"4.1.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Previous studies have suggested that radiation therapy may contribute to an increased risk of subsequent nonkeratinocyte (ie, not squamous and basal cell) skin cancers.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To test the hypothesis that radiation therapy for breast cancer increases the risk of subsequent nonkeratinocyte skin cancers, particularly when these cancers are localized to the skin of the breast or trunk.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This population-based cohort study used longitudinal data from the Surveillance, Epidemiology, and End Results (SEER) Program for January 1, 2000, to December 31, 2019. The SEER database includes population-based cohort data from 17 registries. Patients with newly diagnosed breast cancer were identified and were evaluated for subsequent nonkeratinocyte skin cancer development. Data analysis was performed from January to August 2023.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Radiation therapy, chemotherapy, or surgery for breast cancer.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were standardized incidence ratios (SIRs) for subsequent nonkeratinocyte skin cancer development from 2000 to 2019 based on treatment type (radiation therapy, chemotherapy, or surgery), skin cancer site on the body, and skin cancer subtype.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among the 875\u202f880 patients with newly diagnosed breast cancer included in this study, 99.3% were women, 51.6% were aged older than 60 years, and 50.3% received radiation therapy. A total of 11.2% patients identified as Hispanic, 10.1% identified as non-Hispanic Black, and 69.5% identified as non-Hispanic White. From 2000 to 2019, there were 3839 patients with nonkeratinocyte skin cancer, including melanoma (3419 [89.1%]), Merkel cell carcinoma (121 [3.2%]), hemangiosarcoma (104 [2.7%]), and 32 other nonkeratinocyte skin cancers (195 [5.1%]), documented to occur after breast cancer treatment. The risk of nonkeratinocyte skin cancer diagnosis after breast cancer treatment with radiation was 57% higher (SIR, 1.57 [95% CI, 1.45-1.7]) than that of the general population when considering the most relevant site: the skin of the breast or trunk. When risk at this site was stratified by skin cancer subtype, the SIRs for melanoma and hemangiosarcoma were both statistically significant at 1.37 (95% CI, 1.25-1.49) and 27.11 (95% CI, 21.6-33.61), respectively. Receipt of radiation therapy was associated with a greater risk of nonkeratinocyte skin cancer compared with chemotherapy and surgical interventions.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this study of patients with breast cancer, an increased risk of melanoma and hemangiosarcoma after breast cancer treatment with radiation therapy was observed. Although occurrences of nonkeratinocyte skin cancers are rare, physicians should be aware of this elevated risk to help inform follow-up care.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.1632","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T11:31:19Z","timestamp":1709897479000},"page":"e241632","source":"Crossref","is-referenced-by-count":15,"title":["Incidence of Nonkeratinocyte Skin Cancer After Breast Cancer Radiation Therapy"],"prefix":"10.1001","volume":"7","author":[{"given":"Shawheen J.","family":"Rezaei","sequence":"first","affiliation":[{"name":"Department of Dermatology, Stanford University, Stanford, California"},{"name":"Center for Digital Health, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Eid","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Y.","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison W.","family":"Kurian","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Stanford, California"},{"name":"Department of Epidemiology and Population Health, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice Y.","family":"Kwong","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Linos","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University, Stanford, California"},{"name":"Center for Digital Health, Stanford University, Stanford, California"},{"name":"Department of Epidemiology and Population Health, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"issue":"1","key":"zoi240087r2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.v73.1","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"zoi240087r3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.v72.5","article-title":"Cancer treatment and survivorship statistics, 2022.","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"zoi240087r4","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00432-017-2428-0","article-title":"Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry.","volume":"143","author":"H\u00f6lzel","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"zoi240087r5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer.","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"zoi240087r6","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.ajpath.2013.06.012","article-title":"Breast cancer metastasis: issues for the personalization of its prevention and treatment.","volume":"183","author":"Marino","year":"2013","journal-title":"Am J Pathol"},{"issue":"1","key":"zoi240087r7","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1016\/j.clbc.2020.07.015","article-title":"Breast cancer and secondary cancer recurrences after autologous tissue reconstruction.","volume":"21","author":"Early","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"zoi240087r8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.892923","article-title":"Comparison of breast cancer radiotherapy techniques regarding secondary cancer risk and normal tissue complication probability\u2014modelling and measurements using a 3D-printed phantom.","volume":"12","author":"Vogel","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"zoi240087r9","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/s41598-020-58134-z","article-title":"Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques.","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci Rep"},{"key":"zoi240087r10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.radonc.2020.05.035","article-title":"The risk for developing a secondary cancer after breast radiation therapy: comparison of photon and proton techniques.","volume":"149","author":"Paganetti","year":"2020","journal-title":"Radiother Oncol"},{"issue":"4","key":"zoi240087r11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00268-015-3324-x","article-title":"Secondary cancers after radiation therapy for primary prostate or rectal cancer.","volume":"40","author":"Lee","year":"2016","journal-title":"World J Surg"},{"issue":"2","key":"zoi240087r12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3857\/roj.2020.00213","article-title":"Late side effects of radiation treatment for head and neck cancer.","volume":"38","author":"Brook","year":"2020","journal-title":"Radiat Oncol J"},{"issue":"4","key":"zoi240087r13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000509779","article-title":"Mammary chain irradiation in left-sided breast cancer: can we reduce the risk of secondary cancer and ischaemic heart disease with modern intensity-modulated radiotherapy techniques?","volume":"16","author":"Figlia","year":"2021","journal-title":"Breast Care (Basel)"},{"key":"zoi240087r14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.713328","article-title":"Estimation of annual secondary lung cancer deaths using various adjuvant breast radiotherapy techniques for early-stage cancers.","volume":"11","author":"Pignol","year":"2021","journal-title":"Front Oncol"},{"issue":"5","key":"zoi240087r15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ijc.v111:5","article-title":"Association between female breast cancer and cutaneous melanoma.","volume":"111","author":"Goggins","year":"2004","journal-title":"Int J Cancer"},{"issue":"6","key":"zoi240087r17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/bjd.v184.6","article-title":"Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity.","volume":"184","author":"Laskar","year":"2021","journal-title":"Br J Dermatol"},{"issue":"1","key":"zoi240087r18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","article-title":"Epidemiology and risk factors of melanoma.","volume":"100","author":"Carr","year":"2020","journal-title":"Surg Clin North Am"},{"issue":"2","key":"zoi240087r19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaad.2021.12.066","article-title":"Skin cancer: primary, secondary, and tertiary prevention. Part I.","volume":"87","author":"Perez","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"zoi240087r20","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1001\/jamainternmed.2016.5008","article-title":"Skin cancer\u2014the importance of prevention.","volume":"176","author":"Linos","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"15","key":"zoi240087r21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/jama.2023.4045","article-title":"Screening and prevention of skin cancer.","volume":"329","author":"Jin","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"zoi240087r22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.det.2007.08.005","article-title":"Radiation therapy toxicity to the skin.","volume":"26","author":"Fitzgerald","year":"2008","journal-title":"Dermatol Clin"},{"issue":"3","key":"zoi240087r23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/tbj.v26.3","article-title":"Radiation-induced angiosarcoma of the breast: a review.","volume":"26","author":"Bonito","year":"2020","journal-title":"Breast J"},{"issue":"4S","key":"zoi240087r24","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1097\/SAP.0000000000002098","article-title":"Radiation-induced skin fibrosis: pathogenesis, current treatment options, and emerging therapeutics.","volume":"83","author":"Borrelli","year":"2019","journal-title":"Ann Plast Surg"},{"issue":"3","key":"zoi240087r25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/pbc.v60.3","article-title":"Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.","volume":"60","author":"Pappo","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"zoi240087r26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/00000421-200212000-00014","article-title":"Cutaneous angiosarcoma of breast after lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast carcinoma: case report and review of the literature.","volume":"25","author":"Mermershtain","year":"2002","journal-title":"Am J Clin Oncol"},{"issue":"9804","key":"zoi240087r27","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"zoi240087r28","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.jid.2019.02.033","article-title":"Skin cancer early detection practices among adult survivors of childhood cancer treated with radiation.","volume":"139","author":"Geller","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"12","key":"zoi240087r29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/jamadermatol.2021.3884","article-title":"Association between melanoma detected during routine skin checks and mortality.","volume":"157","author":"Watts","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"2","key":"zoi240087r30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jaad.2021.03.109","article-title":"United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019.","volume":"85","author":"Aggarwal","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"zoi240087r31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/cncr.v118.2","article-title":"Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data.","volume":"118","author":"Jagsi","year":"2012","journal-title":"Cancer"},{"key":"zoi240087r1","unstructured":"Centers for Disease Control and Prevention. U.S. cancer statistics: highlights from 2020 mortality and incidence with comparison to 2019 incidence to assess the effect of the COVID-19 pandemic. U.S. Cancer Statistics Data Briefs, No. 35. June 2023. Accessed February 6, 2024. https:\/\/www.cdc.gov\/cancer\/uscs\/about\/data-briefs\/no35-USCS-highlights-2020.htm"},{"key":"zoi240087r16","unstructured":"National Cancer Institute. Site Recode ICD-O-3\/WHO 2008 definition. Surveillance, Epidemiology, and End Results Program. Accessed June 29, 2023. https:\/\/seer.cancer.gov\/siterecode\/icdo3_dwhoheme\/index.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2815839\/rezaei_2024_oi_240087_1709046812.38963.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T11:31:22Z","timestamp":1709897482000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2815839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.1632","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]}}}